1. Home
  2. ACOG vs STIM Comparison

ACOG vs STIM Comparison

Compare ACOG & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACOG
  • STIM
  • Stock Information
  • Founded
  • ACOG 2000
  • STIM 2003
  • Country
  • ACOG Canada
  • STIM United States
  • Employees
  • ACOG N/A
  • STIM N/A
  • Industry
  • ACOG
  • STIM Medical/Dental Instruments
  • Sector
  • ACOG
  • STIM Health Care
  • Exchange
  • ACOG Nasdaq
  • STIM Nasdaq
  • Market Cap
  • ACOG 80.3M
  • STIM 232.3M
  • IPO Year
  • ACOG N/A
  • STIM 2018
  • Fundamental
  • Price
  • ACOG $9.33
  • STIM $3.52
  • Analyst Decision
  • ACOG Strong Buy
  • STIM Buy
  • Analyst Count
  • ACOG 1
  • STIM 4
  • Target Price
  • ACOG $20.00
  • STIM $6.00
  • AVG Volume (30 Days)
  • ACOG 76.9K
  • STIM 818.0K
  • Earning Date
  • ACOG 08-14-2025
  • STIM 08-11-2025
  • Dividend Yield
  • ACOG N/A
  • STIM N/A
  • EPS Growth
  • ACOG N/A
  • STIM N/A
  • EPS
  • ACOG N/A
  • STIM N/A
  • Revenue
  • ACOG $2,928,654.00
  • STIM $89,448,000.00
  • Revenue This Year
  • ACOG N/A
  • STIM $104.65
  • Revenue Next Year
  • ACOG N/A
  • STIM $10.69
  • P/E Ratio
  • ACOG N/A
  • STIM N/A
  • Revenue Growth
  • ACOG N/A
  • STIM 22.16
  • 52 Week Low
  • ACOG $3.75
  • STIM $0.52
  • 52 Week High
  • ACOG $11.40
  • STIM $5.92
  • Technical
  • Relative Strength Index (RSI)
  • ACOG N/A
  • STIM 35.49
  • Support Level
  • ACOG N/A
  • STIM $3.26
  • Resistance Level
  • ACOG N/A
  • STIM $3.61
  • Average True Range (ATR)
  • ACOG 0.00
  • STIM 0.18
  • MACD
  • ACOG 0.00
  • STIM -0.01
  • Stochastic Oscillator
  • ACOG 0.00
  • STIM 37.38

About ACOG Alpha Cognition Inc. Common Stock

Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, for which there are limited or no treatment options. The Company's current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Company's commercial development program for ZUNVEYL is primarily focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.

About STIM Neuronetics Inc.

Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.

Share on Social Networks: